Study ID Number Study Title Institute Species Analysis
ST0003561 metabolitesGC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum dataUniversity of HawaiiHomo sapiensMS
ST0005091 metabolitesMetabolic changes to maternal rat liver tissue during and post-pregnancy (part I)University of Colorado, DenverRattus norvegicusMS
ST0005101 metabolitesAssessing metabolic changes to maternal rat liver tissue during and post-pregnancy (part II)University of Colorado, DenverMus musculusMS
ST0013041 metabolitesMulti-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondiiMonash UniversityToxoplasma gondiiMS
ST0014471 metabolitesMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Colon ICMSUniversity of KentuckyMus musculusMS
ST0014531 metabolitesMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Liver ICMSUniversity of KentuckyMus musculusMS
ST0014701 metabolitesMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Lung ICMSUniversity of KentuckyMus musculusMS
ST0014721 metabolitesMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Small Intestines ICMSUniversity of KentuckyMus musculusMS
ST0014741 metabolitesMetabolomics of lung injury after allogeneic hematopoietic cell transplantation - Spleen ICMSUniversity of KentuckyMus musculusMS
ST0015492 metabolitesβ-Adrenergic regulation of metabolism in macrophages (part-III)Monash UniversityHomo sapiensMS
ST0016101 metabolitesControl (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hoursOhio UniversityHomo sapiensMS
ST0016111 metabolitesMouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatmentNorth Carolina State UniversityMus musculusMS
ST0016801 metabolitesMetabolome of NAFLD in high fat diet mouse modelWeill Cornell MedicineMus musculusMS
ST0017301 metabolitesMitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistanceUniversity of Colorado DenverHomo sapiensMS
ST0017311 metabolitesMitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance (part-II)University of Colorado DenverHomo sapiensMS
ST0017591 metabolitesApplication of the redox metabolite detection method for mouse liverBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017601 metabolitesApplication of the redox metabolite detection method for mouse kidneyBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017611 metabolitesApplication of the redox metabolite detection method for mouse biofluidsBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017621 metabolitesApplication of the redox metabolite detection method for mouse kidney (part II)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017631 metabolitesApplication of the redox metabolite detection method for mouse liver (part II)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017641 metabolitesApplication of the redox metabolite detection method for profiling redox state following pharmacologic perturbation with methotrexateBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0017651 metabolitesOptimization of redox metabolite detection in mammalian cells (part I)Boston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0017661 metabolitesApplication of the redox metabolite detection method for mammalian tissues (part I)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0017681 metabolitesApplication of the redox metabolite detection method for mammalian tissues (part III)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0018501 metabolitesUnbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytesUniversity of Texas MD Anderson Cancer CenterMus musculusMS
ST0019542 metabolitesA pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s AtaxiaUniversity of California, Los AngelesSaccharomyces cerevisiaeMS
ST0019741 metabolitesAnti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (I)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0019751 metabolitesAnti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (II)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0019761 metabolitesAnti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (III)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0019771 metabolitesAnti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (IV)Boston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0019781 metabolitesAnti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (V)Boston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0019791 metabolitesAnti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (VI)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0020331 metabolitesIrradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Prestool)University of Colorado Anschutz Medical CampusMus musculusMS
ST0020341 metabolitesIrradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Poststool)University of Colorado Anschutz Medical CampusMus musculusMS
ST0020361 metabolitesIrradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Kidney)University of Colorado Anschutz Medical CampusMus musculusMS
ST0020371 metabolitesIrradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Liver)University of Colorado Anschutz Medical CampusMus musculusMS
ST0020391 metabolitesIrradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Brain)University of Colorado Anschutz Medical CampusMus musculusMS
ST0020581 metabolitesMuscle/Lung/Tumor metabolomicsUniversity of Colorado Anschutz Medical CampusMus musculusMS
ST0021151 metabolitesLC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cellsUniversity of Texas MD Anderson Cancer CenterHomo sapiensMS
ST0021191 metabolitesMetabolomics analysis of zebrafish response to CID661578 treatmentNorth Carolina State UniversityDanio rerioMS
ST0022001 metabolitesHuman Trisome Project Plasma Metabolomics v1University of Colorado DenverHomo sapiensMS
ST0022131 metabolitesMetabolic changes in Alzheimer patient-derived induced neurons versus non-demented controlsUniversity of Colorado DenverHomo sapiensMS
ST0023711 metabolitesHigh-resolution metabolomics analysis of NLRP3 inflammasome activated macrophagesWake Forest School of MedicineMus musculusMS
ST0024121 metabolitesMetabolic effects of the protein kinase RHudsonMus musculusMS
ST0024771 metabolitesNeutrophil metabolomics in COVID-19UT Southwestern Medical CenterHomo sapiensMS
ST0027081 metabolitesLevels of central carbon metabolites in choroid plexus as part of natural diurnal variationBoston Childrens HospitalMus musculusMS
ST0027092 metabolitesFH variant pathogenicity promotes purine salvage pathway dependence in kidney cancerUniversity of California, Los AngelesNCCFH1, UOK262, UTFHC1MS
ST0028142 metabolitesAtlas of fetal metabolism during mid-to-late gestation and diabetic pregnancyUniversity of California, Los AngelesMus musculusMS
ST0028311 metabolitesFolate depletion upregulates heme synthesisBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0028522 metabolitesMYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerUniversity of California, Los AngelesMus musculusMS
ST0028781 metabolitesAtlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment.University of California, Los AngelesMus musculusMS
ST0028951 metabolitesPolar metabolite levels in K562 cells following folate depletion and inosine supplementationBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0028961 metabolitesPolar metabolite levels in MEL cells following folate depletion and inosine supplementationBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0028971 metabolitesPolar metabolite levels in K562 cells following folate depletion, SHIN1 or AICAR treatmentBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0028981 metabolitesPolar metabolite levels in MEL cells following folate depletion, SHIN1 or AICAR treatmentBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0029061 metabolitesPolar metabolite levels in K562 cells following short-term folate depletionBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0029121 metabolitesPolar metabolite levels in MEL cells following folate depletionBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0029131 metabolitesPolar metabolite levels in K562 cells following folate depletionBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0030181 metabolitesPolar metabolite levels in K562 cells following PKC inhibition in 2,000 nM or 100 nM FA conditionsBoston Children's Hospital, Harvard Medical SchoolHomo sapiensMS
ST0030201 metabolitesPolar metabolite levels in MEL cells following PKC inhibition in 2,000 nM or 100 nM FA conditionsBoston Children's Hospital, Harvard Medical SchoolMus musculusMS
ST0030241 metabolitesIdentifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1Monash Institute of Pharmaceutical SciencesPseudomonas aeruginosaMS
ST0030362 metabolitesIdentifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2Monash Institute of Pharmaceutical SciencesPseudomonas aeruginosaMS
ST0030531 metabolitesProviding insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomicsMonash UniversityStaphylococcus aureusMS
ST0030831 metabolitesMetabolome changes in embryonic CSF (Part 5)Boston Children's Hospital, Harvard Medical SchoolMus musculusMS

Return to search page
  logo